Page last updated: 2024-11-07

2-diphenylmethylpiperidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-diphenylmethylpiperidine: structure given in first source; RN given refers to compound with no isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160506
SCHEMBL ID729266
MeSH IDM0225504

Synonyms (31)

Synonym
2-diphenylmethylpiperidine
OPREA1_652788
AKOS001476367
STK893433
2-(diphenylmethyl)piperidine
2-benzhydrylpiperidine
2-(diphenylmethyl)piperidine; 2-benzhydrylpiperidine
A19451
A828867
519-74-4
49unk1bv8t ,
desoxypipradrol
2-dpmp
unii-49unk1bv8t
deoxypipradol
hsdb 8015
einecs 208-276-6
AM20080665
piperidine, 2-(diphenylmethyl)-
BBL020743
SCHEMBL729266
(+/-)-desoxypipradrol
2-diphenylmethylpiperidine [hsdb]
desoxypipradol
RWTNXJXZVGHMGI-UHFFFAOYSA-N
J-509279
DTXSID90897502
Q414480
LE-0263
desoxypipradrol (1mg/ml in methanol)
PD048829
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.31 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (28.57%)6.00%
Case Studies1 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other4 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]